Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population

被引:4
作者
Mongale, Emily [1 ,5 ]
Allen, Samantha [1 ]
Brew, Iain [1 ]
Ludlow-Rhodes, Arran [1 ]
Royal, Nichola [1 ]
Waldron, Julia [1 ]
Alexander, Hannah [1 ,2 ]
Christensen, Lee [3 ]
Dorrington, Kate [4 ]
Milner, Andrew [4 ]
Missen, Louise [4 ]
Jones, Andy [4 ]
Troke, Philip J. F. [4 ]
机构
[1] Practice Plus Grp, Hawker House,5-6 Napier Court,Napier Rd, Reading RG1 8BW, Berks, England
[2] Def Primary Healthcare, Tidworth, England
[3] Hepatitis C Trust, 27 Crosby Row, London SE1 3YD, England
[4] Gilead Sci Ltd, 280 High Holborn, London WC1V 7EE, England
[5] Practice Plus Grp, Hawker House,5-6 Napier Court,Napier Rd, Reading RG1 8BW, Berks, England
关键词
Hepatitis C; Elimination; Direct-acting antiviral; Prison; Peers; Nurse-led; Screening; HEPATITIS-C VIRUS; INJECT DRUGS; PEOPLE; CARE; ACCEPTABILITY; IMPACT;
D O I
10.1016/j.jhepr.2023.100937
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Micro-elimination of hepatitis C virus (HCV) in high-risk populations is a feasible approach towards achieving the World Health Organization's targets for viral hepatitis elimination by 2030. Prisons represent an area of high HCV prevalence and so initiatives that improve testing and treatment of residents are needed to eliminate HCV from prisons. This initiative aimed to improve the HCV screening and treatment rates of new residents arriving at prisons in England. Methods: A rapid test and treat pathway was developed and implemented in 47 prisons in England between May 2019 and October 2021 as a healthcare service improvement initiative. Prison healthcare staff performed opt-out HCV testing for all new residents at each prison within 7 days of arrival, and those who were positive for HCV RNA were offered treatment with direct-acting antivirals (DAAs). The Hepatitis C Trust provided peer support for all residents on treatment and those who were released into the community. Results: Of 107,260 new arrivals, 98,882 (92.2%) were offered HCV antibody testing, 63,137 (63.9%) were tested and 1,848 were treated. Testing rates increased from 53.7% in Year 1 to 86.0% in Year 3. Between May 2020 and October 2021, 40,727 residents were tested, 2,286 residents were positive for HCV antibodies and 940 residents were HCV RNA positive, giving an antibody prevalence of 5.6% and an RNA prevalence of 2.3%. A total of 921 residents were referred for treatment and 915 initiated DAA treatment (97.3% of whom were HCV RNA positive). Conclusions: This initiative showed that an opt-out HCV test and treat initiative in prison receptions is feasible and can be adapted to the needs of individual prisons as a viable way to achieve HCV micro-elimination. Impact and implications: Prisons represent an area of high HCV prevalence and so initiatives that improve testing and treatment of residents are needed to eliminate HCV from prisons. The reception testing protocol improved HCV screening in new arrivals across 47 prisons in England and could be a viable way for countries to achieve HCV micro-elimination in their prison systems. The reception testing protocol presented here can be adapted to the individual needs of prisons, globally, to improve HCV screening and treatment in this setting.(c) 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:10
相关论文
共 46 条
[1]  
AASLD IDSA, 2021, HCV guidance: recommendations for testing, managing, and treating hepatitis C
[2]  
[Anonymous], 2020, ITV NEWS
[3]   Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia [J].
Bajis, Sahar ;
Maher, Lisa ;
Treloar, Carla ;
Hajarizadeh, Behzad ;
Lamoury, Francois M. J. ;
Mowat, Yasmin ;
SchulZ, Marcel ;
Marshall, Alison D. ;
Cunningham, Evan B. ;
Cock, Victoria ;
Ezard, Nadine ;
Gorton, Carla ;
Hayllar, Jeremy ;
Smith, Julie ;
Whelan, Michelle ;
Martinello, Marianne ;
Applegate, Tanya L. ;
Dore, Gregory J. ;
Grebely, Jason .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 61 :23-30
[4]   Survey of US Correctional Institutions for Routine HCV Testing [J].
Beckwith, Curt G. ;
Kurth, Ann E. ;
Bazerman, Lauri ;
Solomon, Liza ;
Patry, Emily ;
Rich, Josiah D. ;
Kuo, Irene .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (01) :68-71
[5]  
Bottero Julie, 2015, Open Forum Infect Dis, V2, pofv162, DOI 10.1093/ofid/ofv162
[6]   Use and acceptability of salivary hepatitis C virus testing in an English Young Offender Institution [J].
Candfield, Sophie ;
Samuel, Mannampallil I. ;
Ritchie, David ;
McDonald, Candice ;
Brady, Michael ;
Taylor, Chris .
INTERNATIONAL JOURNAL OF STD & AIDS, 2017, 28 (12) :1234-1238
[7]  
Centre for Disease Analysis Foundation, Regions dashboard
[8]  
Coalition for Global Hepatitis Elimination, 2019, Call to action for liver Associations to advance progress towards viral hepatitis elimination: a focus on simplified approaches to HCV testing and cure
[9]   Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm [J].
Cuadrado, Antonio ;
Llerena, Susana ;
Cobo, Carmen ;
Ramon Pallas, Jose ;
Mateo, Miguel ;
Cabezas, Joaquin ;
Ignacio Fortea, Jose ;
Alvarez, Silvia ;
Pellon, Raul ;
Crespo, Juan ;
Echevarria, Santiago ;
Ayesa, Rosa ;
Setien, Esther ;
Lopez-Hoyos, Marcos ;
Crespo-Facorro, Benedicto ;
Aguero, Jesus ;
Chueca, Natalia ;
Garcia, Federico ;
Luis Calleja, Jose ;
Crespo, Javier .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (11) :1639-1648
[10]  
Enggist S., 2014, Prisons and health